Monitoring of the pharmacological treatment availability in patients with multiple sclerosis in the Greater Poland population
Introduction There is no clear explanation for the availability of multiple sclerosis (MS) pharmacological treatment for patients in Greater Poland and it can be assumed that the same reason is common in most of the developed countries in the United Europe. As an autoimmune disease MS can overlap wi...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2024-01-01
|
Series: | Rheumatology |
Subjects: | |
Online Access: | https://reu.termedia.pl/Monitoring-of-the-pharmacological-treatment-availability-in-patients-with-multiple,177143,0,2.html |